Making collaborations work: Pharma companies invest in new relationships with health systems

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

Integrated health systems and delivery networks are challenged to improve the lives of their patients in sickness and in health, in and out of the hospital. The pharma industry has an opportunity to help providers and payers achieve their goals and keep their communities healthy through new research collaborations that can benefit everyone.

HRI research into past and current pharmaceutical and health system collaborations, and interviews with health system executives, reveal an urgent desire to partner differently with the pharmaceutical industry.

Download report

Download chartpack

Most consumers are willing to share some health data with pharmaceutical companies

Consumers are even more likely to share health data when they understand how that data is being used. Providers and health systems are in a unique position to explain to patients the purpose and benefits of sharing health information with pharmaceutical partner organizations.

Contact us

Michael Swanick

Global Pharmaceutical and Life Sciences Leader, PwC US

Douglas Strang

Global Pharmaceutical and Life Sciences Advisory Leader, PwC US

Benjamin Isgur

Health Research Institute Leader, PwC US

Trine K. Tsouderos

HRI Regulatory Center Leader, PwC US

Tel: +1 (312) 241 3824

Follow us